Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.

Celerion leverages over 40 years’ experience, 600 clinic beds (including 24 in-hospital), and facilities located in North America, Europe and Asia, to conduct and analyze First-in-Human, clinical Proof-of-Concept, Cardiovascular Safety Services, ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on clinical data analysis as well as small and large molecule bioanalytical assay services. Regulatory, drug development and program management complement Celerion’s service offerings. For more information please visit www.celerion.com.